Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.19 0.0700 +58.33%
ARIA $9.89 2.9100 +41.69%
EPZM $20.10 2.6000 +14.86%
SNSS $1.21 0.1500 +14.15%
BLRX $1.53 0.1700 +12.50%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CCXI $6.50 -0.3900 -5.66%
NWBO $8.11 -0.1900 -2.29%
PGNX $7.67 -0.1600 -2.04%
VBLT $5.31 -0.1100 -2.03%
PFE $32.66 -0.6000 -1.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

Most Legionnaire's Disease Deaths Tied To Plumbing Systems, CDC Says

(CBS News/HealthDay News) Aug 14, 2015 - As New York City struggles to contain an outbreak of Legionnaires' disease, two new U.S. government reports show the bacteria that causes the potentially deadly illness can take root in a myriad of water sources.
read article 

Fears of Potentially Blinding Complication From Avastin Eye Injections Are Overblown, According To Penn Study

(Penn Medicine) Aug 13, 2015 - Insurance claims data hint at higher infection risk for Lucentis, a more expensive drug.
read press release 

FDA Approves OxyContin for Children As Young As 11

(NBC News) Aug 13, 2015 - The Food and Drug Administration has approved limited use of the powerful and frequently abused painkiller OxyContin for children as young as 11 years old, the agency announced Thursday.
read article 

Drug Executives Seeking Approval for Female Libido Pill Previously Ran Afoul of FDA Rules

(Minneapolis Star Tribune/Associated Press) Aug 14, 2015 - A small drugmaker from North Carolina may succeed next week where many of the world's largest pharmaceutical companies have failed: in winning approval for the first drug to boost women's sexual desire.
read article 

Logistic Toxicity, An Unmeasured Burden of Healthcare

(Forbes) Aug 14, 2015 - I never heard of “logistic toxicity” until last year, when I met Shelley Fuld Nasso at a conference.
read article 

New Cancer Waiting Time Figures Show Thousands Still Facing Delays

(Cancer Research UK) Aug 13, 2015 - Waiting time targets for treating patients referred with suspected cancer have been missed for a sixth successive quarter, according to new NHS England figures.
read article 

New Consensus Recommendations Announced for Standardized Imaging Protocol in Brain Tumor Clinical Trials

(National Brain Tumor Society) Aug 13, 2015 - Brain Tumor Imaging Protocol will reduce variability in magnetic resonance imaging and increase accuracy in determining progression and response of investigational therapies.
read press release 

Interpace Diagnostics Announces Additional Coverage In Top Managed Care Health Plans for Their Thyroid and Pancreas Molecular Diagnostic Tests

(StreetInsider) Aug 13, 2015 - ThyGenX™ and ThyraMIR™ gain coverage with large regional payer; PancraGen™ contracted coverage extended among national and key regional payers.
read article 

NanoString Technologies Receives Favorable Final Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assab

(NASDAQ) Aug 13, 2015 - NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies through its MolDx program, has issued a favorable final local coverage determination (LCD) for the Prosigna® Breast Cancer Assay.
read article 

ASLAN Pharmaceuticals Receives Orphan Drug Designation From the FDA for ASLAN001 (varlitinib) In Cholangiocarcinoma

(ASLAN) Aug 13, 2015 - ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, today announced the Designation as an Orphan drug of their pan-HER inhibitor ASLAN001 (varlitinib) by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD).
read corporate press release 

Cellular Factors That Shape the 3D Landscape of the Genome Identified

(NIH) Aug 13, 2015 - Researchers, using novel large-scale imaging technology, have mapped the spatial location of individual genes in the nucleus of human cells and identified 50 cellular factors required for the proper three-dimensional (3D) positioning of genes.
read press release 

Newly Discovered Cells Regenerate Liver Tissue Without Forming Tumors

(UC San Diego) Aug 13, 2015 - The mechanisms that allow the liver to repair and regenerate itself have long been a matter of debate.
read press release 

New Research Helps Explain Why a Deadly Blood Cancer Often Affects Children with Malaria

(Rockefeller University) Aug 13, 2015 - In equatorial Africa, a region of the globe known as the "lymphoma belt," children are ten times more likely than in other parts of the world to develop Burkitt's lymphoma, a highly aggressive blood cancer that can be fatal if left untreated.
read article 

Memory Problems Due to 'Cancer Brain' and Not 'Chemo Brain'?

(Medscape Medical News) Aug 13, 2015 - Memory problems and cognitive impairment in women with breast cancer have traditionally been blamed on "chemo brain," but a new study shows that there may be problems even before patients start on chemotherapy and suggests that cognitive problems may be linked to cytokines released by the cancer.
read article (free registration required) 

Advance in Photodynamic Therapy Offers New Approach to Ovarian Cancer

(OSU) Aug 13, 2015 - Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.
read press release 

A Better Way to Personalize Bladder Cancer Treatments

(UC Davis) Aug 13, 2015 - Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.
read press release 

Testing for More Breast Cancer Genes Offers Useful Information

(Reuters) Aug 13, 2015 - When the results of a test wouldn’t change how doctors manage a patient’s care, most say it’s not worth doing. But new tests for breast cancer risk mutations beyond the well-known BRCA genes would offer actionable information for many women and their doctors, a new study finds.
read article 

Screening for Breast/Ovarian Cancer Risk Genes Other Than BRCA 1/2 Can Change Clinical Recommendations

(Mass General) Aug 13, 2015 - A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members.
read press release 

Merck and MD Anderson Announce Immuno-Oncology Research Collaboration in Solid Tumors

(MD Anderson) Aug 13, 2015 - Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.
read press release 

Desperately Seeking Price Reform: The Pharmaceutical Industry Needs To Change Its Ways

(Forbes) Aug 13, 2015 - A familiar trope employed at the climax of movie thrillers is the zombie who returns from the dead to devour the brains of the living.
read article 

GSK Hopes Big Clinical Trial Can Breath New Life Into Lung Drug

(Reuters) Aug 13, 2015 - GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result.
read article 

Roche Buys "Superbug" Diagnostics Firm for Up To $425 Mln

(Reuters) Aug 13, 2015 - Roche is buying U.S. diagnostics firm GeneWEAVE BioSciences for up to $425 million, expanding the Swiss group's commitment to fighting so-called "superbugs" as the threat from drug-resistant microbes grows.
read article 

Kyle Bass Says So What If He Challenges Drug Patents for Profits

(Bloomberg) Aug 12, 2015 - Hedge fund manager Kyle Bass said he challenges drug patents for profit -- but so does everyone else.
read article 

Sandra Lee Is Released From Hospital After Surgery for Infection

(New York Times) Aug 12, 2015 - Sandra Lee, the television host and longtime companion of Gov. Andrew M. Cuomo of New York, was released from the hospital on Wednesday, her spokeswoman said, after undergoing surgery meant to address a lingering infection, several months after she had a double mastectomy for breast cancer.
read article 

Jimmy Carter Says He Has Cancer and It Has Spread

(CNN) Aug 13, 2015 - Former President Jimmy Carter has cancer, and it has spread to other parts of his body, he announced Wednesday.
read article